We are pleased to announce a new IRDiRC publication, “Challenges and opportunities for the use of telehealth in rare disease diagnosis, treatment, research, and education: key opinion leader interviews”, produced […]
Read More
IRDiRC is delighted to be represented by multiple members at the Undiagnosed Day 2026 taking place in Gdansk (Poland) and online. Bringing together specialist clinicians, clinical geneticists, and invited experts, […]
Read More
How can innovative financing approaches improve equitable access to diagnosis, treatment, and care for people living with rare diseases? On behalf of Rare Diseases International, member of IRDiRC Patient Advocates Constituent […]
Read MoreWhat could healthcare look like in 2035 – if we act with the urgency that rare diseases demand? At DIA Europe 2026 panel session in Rotterdam (Netherlands), chaired and convened […]
Read MoreOn Rare Disease Day 2026, International Rare Diseases Research Consortium reaffirms its unwavering commitment to advancing research for the 300 million people and families living with rare diseases worldwide. With more than […]
Read MoreIRDiRC is excited to share its latest interview featuring Maria Cavaller Belaubi (EURORDIS-Rare Diseases Europe, Spain), co-chair of the “Engagement of Young People Living with Rare Diseases in Therapy Development” […]
Read MoreJust ahead of Rare Disease Day, the International Rare Diseases Research Consortium (IRDiRC) Task Force on Stigma and Rare Diseases convened a pivotal two-day workshop in Paris to tackle one of the […]
Read More
IRDiRC is pleased to share that Shirlene Badger has been elected Vice-Chair of the International Rare Diseases Research Consortium’s Companies Constituent Committee (CCC). Shirlene leads Global Patient Advocacy at Illumina […]
Read More
The IRDiRC Companies Constituent Committee (CCC) is pleased to welcome PacBio as its newest member, represented by Nina Gonzaludo, Global Lead Human Genomics, based in the USA. PacBio is a global leader in long-read sequencing […]
Read More
The International Rare Diseases Research Consortium will be at the forefront of discussions at World Orphan Drug Congress USA 2026, highlighting innovations in rare disease research, personalized therapies, and sustainable approaches to genetic […]
Read More